A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2011
10/13/2011	US20110250228 Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin
10/13/2011	US20110250212 Therapy procedure for drug delivery for trigeminal pain
10/13/2011	US20110250208 Oxidized Cardiolipin as a Novel Pro-Inflammatory Factor
10/13/2011	US20110250200 Soluble lymphotoxin-beta receptor fusion protein and methods for inhibiting lymphotoxin beta-receptor signaling
10/13/2011	US20110250199 Immunotoxins and uses thereof
10/13/2011	US20110250198 ActRIIB FUSION POLYPEPTIDES AND USES THEREFOR
10/13/2011	US20110250194 Treatment with Anti-ErbB2 Antibodies
10/13/2011	US20110250193 Composition comprising expression or activity inhibitors of ninjurin1 for the prevention and treatment of inflammatory disease
10/13/2011	US20110250192 Use of microrna signatures for assessing risk levels of neuroblastoma patients
10/13/2011	US20110250191 Composition for enhancing physical performance
10/13/2011	US20110250187 Compositions and methods for treating hypophosphatasia
10/13/2011	US20110250183 Combination Therapy for Treatment of Patients with Neurological Disorders and Cerebral Infarction
10/13/2011	US20110250181 Human lysosomal proteins from plant cell culture
10/13/2011	US20110250180 Ccn3 peptides and analogs thereof for therapeutic use
10/13/2011	US20110250179 Methods for treatment and diagnosis of cancer
10/13/2011	US20110250177 Alpha interferon variants
10/13/2011	US20110250176 Combinations of Hepatitis C Virus Inhibitors
10/13/2011	US20110250175 Tlr7 ligand and uses thereof
10/13/2011	US20110250174 Stable immunogenic product comprising antigenic heterocomplexes
10/13/2011	US20110250173 Methods and compositions for inhibition of Treg cells
10/13/2011	US20110250172 Hepatitis c virus inhibitors
10/13/2011	US20110250171 Compositions and Methods for Cancer Immunotherapy
10/13/2011	US20110250170 Immunocytokines for Tumour Therapy with Chemotherapeutic Agents
10/13/2011	US20110250169 Derivatives of growth hormone and related proteins
10/13/2011	US20110250168 Sialoadhesin-related compositions and methods
10/13/2011	US20110250167 Method for purifying proteins
10/13/2011	US20110250166 Combination of rocaglamide and apoptosis inducing substances for the treatment of cancer
10/13/2011	US20110250165 Antibodies against CXCR4 and Methods of Use Thereof
10/13/2011	US20110250163 Mono- and di-peg il-10 production; and uses
10/13/2011	US20110250153 Oligomeric biosurfactants in dermatocosmetic compositions
10/13/2011	US20110250144 Rgd-containing peptidomimetics and uses thereof
10/13/2011	US20110250134 Sustained release nitric oxide from long lived circulating nanoparticles
10/13/2011	US20110250132 Lipoic acid metabolite: useful for drug carrier, nanoparticle conjugate, imaging and hyperthermia therapy
10/13/2011	US20110250130 Tnf-alpha binding proteins
10/13/2011	CA2796012A1 Preparation of recombinant human plasma phospholipid transfer protein (pltp) from the milk of transgenic animals
10/13/2011	CA2795789A1 Btnl9 proteins, nucleic acids, and antibodies and uses thereof
10/13/2011	CA2795765A1 Methods for identifying and using inhibitors of casein kinase 1 epsilon isoform for inhibiting the growth and/or proliferation of myc-driven tumor cells
10/13/2011	CA2795390A1 Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof
10/13/2011	CA2795289A1 Methods and compositions for enhanced delivery of compounds
10/13/2011	CA2793940A1 Therapeutic use of the .beta.2m protein
10/12/2011	EP2374885A2 ENA nucleic acid drugs modifying splicing in mRNA precursor
10/12/2011	EP2374878A2 Novel adamts-13 mutant
10/12/2011	EP2374876A2 Therapy for alpha-galactosidase a deficiency
10/12/2011	EP2374872A2 A method for the high level expression of active lymphotoxin-beta receptor immunoglobulin chimeric proteins and their purification
10/12/2011	EP2374871A1 Pluripotent stem cells, method for preparation thereof and uses thereof
10/12/2011	EP2374870A2 Use of OP-1 for the preparation of a pharmaceutical composition for reparing a defect locus in a non articular cartilage tissue of a mammal
10/12/2011	EP2374819A1 Antibodies to MASP-2
10/12/2011	EP2374814A2 Peptides that ellicit T cellular immunity
10/12/2011	EP2374812A2 4-amino-4-oxobutanoyl Peptides as Inhibitors of Viral Replication
10/12/2011	EP2374507A1 Compositions and methods for treatment of body weight conditions with milk minerals, casein fractions and enzyme inhibitor
10/12/2011	EP2374472A2 Compositions and methods for treating ophthalmic disorders
10/12/2011	EP2374471A1 Injectable hardenable calcium phosphate pastes for delivery of osteogenic proteins
10/12/2011	EP2374470A1 Therapeutic use of the Beta2m protein
10/12/2011	EP2374469A2 Compositions and methods for promoting wound healing and tissue regeneration
10/12/2011	EP2374468A1 Use of apl-type peptide for treating intestinal inflammatory diseases and type 1 diabetes
10/12/2011	EP2374467A1 Protective staphylococcus aureus vaccine based on cell wall-associated proteins
10/12/2011	EP2374466A1 Protective staphylococcus aureus vaccine based on cell wall-associated proteins
10/12/2011	EP2374465A1 Peptide-based conditioners and colorants for hair, skin and nails
10/12/2011	EP2374464A2 HCV N3S-NS4A protease inhibition
10/12/2011	EP2374454A1 Hemiasterlin derivatives and uses thereof in the treatment of cancer
10/12/2011	EP2374452A1 Nutrient composition
10/12/2011	EP2374005A1 Methods and uses involving heme binding protein 1
10/12/2011	EP2373791A1 Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus on surfaces
10/12/2011	EP2373789A1 Membrane type-1 matrix metalloprotein inhibitors and uses thereof
10/12/2011	EP2373693A1 Compositions and methods for the treatment or the prevention oral infections by e. coli
10/12/2011	EP2373682A1 Treatment of early-stage osteoarthritis
10/12/2011	EP2373681A1 Pharmaceutical compositions
10/12/2011	EP2373678A1 Anticancer compounds
10/12/2011	EP2373343A1 Immunocytokines for tumour therapy with chemotherapeutic agents
10/12/2011	EP2373338A2 Annexina2 as immunological target
10/12/2011	EP2373330A2 Methods for diagnosing and treating autoimmune disorders
10/12/2011	EP2373329A2 Use of epidermal growth factor inhibitors in the treatment of viral infection
10/12/2011	EP2373328A2 Stroke-generated angiogenesis enhancers and uses thereof
10/12/2011	EP2373327A1 Composition comprising expression or activity inhibitors of ninjurin 1 for the prevention and treatment of inflammatory disease
10/12/2011	EP2373296A2 Formulations of guanylate cyclase c agonists and methods of use
10/12/2011	EP2373294A1 Clostridial toxin pharmaceutical compositions
10/12/2011	EP2373160A1 Topically active steroids for use in radiation and chemotherapeutics injury
10/12/2011	EP2252322B1 Vaccine compositions
10/12/2011	EP2134165B1 Compositions and methods including expression and bioactivity of bovine follicle stimulating hormone
10/12/2011	EP2051991B1 Cardioprotective compounds
10/12/2011	EP2019680B1 Augmentation of titer for vaccination in animals
10/12/2011	EP1652923B1 Gene overexpressed in cancer
10/12/2011	EP1541584B1 A group of novel synthetic antibiotic peptides
10/12/2011	EP1366022B1 Rgd-analog non-peptidic molecules having anti-adhesive, anti-migration and anti-proliferative effects
10/12/2011	EP1263471B1 Antimicrobial compounds and formulations
10/12/2011	EP1191096B1 Ovel protein and dna thereof
10/12/2011	CN102216775A Susceptibility to hsp90-inhibitors
10/12/2011	CN102216326A Compositions and methods of use for thrombomodulin variants
10/12/2011	CN102216323A Il-4-derived peptides for modulation of the chronic inflammatory response and treatment of autoimmune diseases
10/12/2011	CN102216322A Inhibiting interaction between the hif-1alpha and p300/cbp with hydrogen bond surrogate-based
10/12/2011	CN102215876A Method for the treatment of radiation-induced neutropenia by administration of a multi-pegylated granulocyte colony stimulating factor (g-csf) variant
10/12/2011	CN102215869A Methods and compositions for regulating iron homeostasis by modulation bmp-6
10/12/2011	CN102215860A Methods of treating cognitive impairment
10/12/2011	CN102215859A Use of pituitary adenylate cyclase-activating polypeptide (pacap) and pacap analogs as adjunctive treatments with anticancer agents
10/12/2011	CN102215858A Methods of treatment using single doses of oritavancin
10/12/2011	CN102215838A Use of alkanoyl l-carnitine in combination with chemotherapeutic agents for the treatment of neoplasms
10/12/2011	CN102215837A Nutritional support to prevent and/or mitigate bone marrow toxicity from a cancerous tumor
10/12/2011	CN102215836A Nutritional support to prevent or moderate bone marrow paralysis or neutropenia during anti-cancer treatment
10/12/2011	CN102215824A Solid pharmaceutical formulation with delayed release
10/12/2011	CN102212596A Preparation method of human epidermal growth factor

1 ... 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 ... 3163